Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
TERN
TERN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
TERN News
Viking Therapeutics CEO Highlights Broad Strategic Interest in Weight-Loss Drug Deals, Shares Surge 17%
Jan 14 2026
stocktwits
CleanSpark Inc. (CLSK) Jumps 14.13% Ahead of Mining Report for December 2025
Jan 03 2026
Yahoo Finance
Terns Pharmaceuticals Grants 312,000 Stock Options to New Employees
Jan 02 2026
Globenewswire
Palvella Therapeutics Stock Soars to $114.69 Following Pipeline Developments
Dec 31 2025
NASDAQ.COM
Terns Pharmaceuticals (TERN) Sees Price Target Raised by 75.91% to 54.63
Dec 21 2025
NASDAQ.COM
Cramer's Lighting Round: Exercise Caution with Lumen Technologies
Dec 16 2025
CNBC
Terns Pharmaceuticals Closes $747.5 Million Public Offering of 18.69 Million Shares
Dec 11 2025
Globenewswire
Terns Pharmaceuticals Prices Upsized Offering of 16.25 Million Shares at $40 Each, Raising $650 Million
Dec 10 2025
Globenewswire
Cancer Research Boosts Confidence in These Small Biotech Companies
Dec 09 2025
Barron's
Broadcom Set for Approximately 10% Surge? Check Out 10 Leading Analyst Predictions for Tuesday
Dec 09 2025
Benzinga
Small Biotech Terns Targets Novartis' Leading Leukemia Drug
Dec 09 2025
Benzinga
Terns Pharmaceuticals Proposes $400 Million Public Offering to Fund R&D
Dec 09 2025
Globenewswire
Terns Pharmaceuticals Initiates $400 Million Public Offering
Dec 09 2025
NASDAQ.COM
Terns Pharmaceuticals Reports 64% MMR Achievement with TERN-701 in CML Patients
Dec 08 2025
Newsfilter
Broadcom Set to Surge by 13%? Check Out 10 Leading Analyst Predictions for Wednesday
Nov 26 2025
Benzinga
Citizens Upgrades Terns Pharma to Market Outperform and Increases Price Target to $35
Nov 26 2025
Benzinga
Show More News
